Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVelocity Comp Regulatory News (VEL)

Share Price Information for Velocity Comp (VEL)

Share Price is delayed by 15 minutes
Get Live Data
16.25    0.00 (0.00%)
Bid:
16.00
Ask:
16.50
Spread: 0.50 (3.125%)
Market Cap: £8.88m
VEL Live PriceLast checked at - London Stock Exchange

Intraday Velocity Comp Share Chart

TR-1 Notification

30 Mar 2011 18:08

RNS Number : 9630D
Velti PLC
30 March 2011
Β 

ο»Ώ

Β 

For filings with the FSA include the annex

For filings with issuer exclude the annex

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

Velti Plc

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

ΓΌ

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

3. Full name of person(s) subject to thenotification obligation: iii

FMR LLC

4. Full name of shareholder(s) Β (if different from 3.):iv

FMR LLC is the parent holding company of Fidelity Management & Research Company (FMRCO), Investment manager for US mutual funds, FIL Management Trust Company (FMTC), Pyramis Global Advisors Trust Company(PGATC), a US state chartered bank which acts as a trustee or investment manager of various pension and trust accounts, Pyramis Global Advisors LLC (PGALLC) and Pyramis Trust Company (PTC).

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

29 March 2011

6. Date on which issuer notified:

30 March 2011

7. Threshold(s) that is/are crossed orreached: vi, vii

5%

Β 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Indirect

Direct xi

Indirect xii

Direct

Indirect

JE00B41PDC45

2,963,733

2,963,733

2,522,674

2,522,674

4.96

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

Β 

% of voting rights xix, xx

Β 

Β 

Β 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

2,522,674

4.96%

Β 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

Β 

SHARES HELD

NOMINEE

MANAGEMENT COMPANY

2,007,442

BROWN BROTHERS HARRIMAN ANC CO

FMRCO

240,932

JP MORGAN CHASE BANK

FMRCO

269,100

MELLON BANK N.A.

FMRCO

5,200

CITIBANK NA (C)

FMR

Proxy Voting:

10. Name of the proxy holder:

FMR LLC

11. Number of voting rights proxy holder will cease to hold:

441,059

12. Date on which proxy holder will cease to hold voting rights:

29 March 2011

13. Additional information:

None

14. Contact name:

Philip Alexander

15. Contact telephone number:

Β 

fil-regreporting@fil.com, 01737 834624

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
HOLBLGDXCUXBGBG
Date   Source Headline
12th Mar 20244:50 pmRNSResult of AGM
11th Mar 20242:17 pmRNSAppointment of Chief Financial Officer
11th Mar 20247:00 amRNSUpdate on US Contract and OEM Approvals
13th Feb 20247:00 amRNSAppointment of Dowgate Capital as Joint Broker
24th Jan 20247:00 amRNSGrant of Share Options & Issue of Equity
23rd Jan 20247:00 amRNSFinal Results for the year ended 31 October 2023
11th Jan 20247:00 amRNSNotice of Results and Investor Presentation
10th Oct 20234:43 pmRNSHolding(s) in Company
9th Oct 20235:00 pmRNSHolding(s) in Company
9th Oct 20234:59 pmRNSHolding(s) in Company
9th Oct 20232:51 pmRNSHolding(s) in Company
5th Oct 20234:57 pmRNSHolding(s) in Company
28th Sep 202312:53 pmRNSShare Premium Reduction Effective
31st Aug 20234:30 pmRNSTotal Voting Rights
29th Aug 20236:21 pmRNSResults of General Meeting
23rd Aug 20232:46 pmRNSDirectorate Change
18th Aug 202310:45 amRNSHolding(s) in Company
16th Aug 20234:26 pmRNSHolding(s) in Company
15th Aug 20237:00 amRNSFurther Subscription
14th Aug 20233:38 pmRNSResults of REX Retail Offer & Total Voting Rights
26th Jul 20237:00 amRNSTrading Update
11th Jul 20237:00 amRNSHalf Year Results
24th May 20237:00 amRNSTrading Update & Notice of Results
18th Apr 20237:00 amRNSMajor milestone achieved at new Alabama facility
31st Mar 20234:30 pmRNSTotal Voting Rights
29th Mar 20233:30 pmRNSGrant of Share Options to Directors/PDMRs
27th Mar 202310:20 amRNSPDMR Shareholding
17th Mar 20234:37 pmRNSPDMR Shareholding
6th Mar 20237:00 amRNSExercise of Options and Issue of Equity
28th Feb 20232:08 pmRNSResults of Annual General Meeting
2nd Feb 20234:30 pmRNSPublication of Annual Report and Notice of AGM
1st Feb 202311:05 amRNSSecond Price Monitoring Extn
1st Feb 202311:00 amRNSPrice Monitoring Extension
30th Jan 20234:25 pmRNSDirector/PDMR Shareholding
24th Jan 20237:00 amRNSFinal Results
18th Jan 20234:40 pmRNSSecond Price Monitoring Extn
18th Jan 20234:35 pmRNSPrice Monitoring Extension
18th Jan 20232:05 pmRNSSecond Price Monitoring Extn
18th Jan 20232:00 pmRNSPrice Monitoring Extension
17th Jan 20234:40 pmRNSSecond Price Monitoring Extn
17th Jan 20234:35 pmRNSPrice Monitoring Extension
17th Jan 20232:05 pmRNSSecond Price Monitoring Extn
17th Jan 20232:00 pmRNSPrice Monitoring Extension
12th Jan 20234:40 pmRNSSecond Price Monitoring Extn
12th Jan 20234:35 pmRNSPrice Monitoring Extension
12th Jan 20232:05 pmRNSSecond Price Monitoring Extn
12th Jan 20232:00 pmRNSPrice Monitoring Extension
11th Jan 20237:00 amRNSInvestor Presentation
22nd Dec 20229:14 amRNSHolding(s) in Company
20th Dec 20222:05 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.